These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22670778)

  • 1. Circulating ficolin-2 and ficolin-3 in normal pregnancy and pre-eclampsia.
    Halmos A; Rigó J; Szijártó J; Füst G; Prohászka Z; Molvarec A
    Clin Exp Immunol; 2012 Jul; 169(1):49-56. PubMed ID: 22670778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia.
    Molvarec A; Szarka A; Walentin S; Szucs E; Nagy B; Rigó J
    Hypertens Res; 2010 Sep; 33(9):892-8. PubMed ID: 20535121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OS004. A link between the complement system and angiogenic imbalance inpreeclampsia: ficolin-2 deficiency.
    Molvarec A; Halmos A; Szijártó J; Csuka D; Füst G; Prohászka Z; Rigó J
    Pregnancy Hypertens; 2012 Jul; 2(3):177. PubMed ID: 26105219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia.
    Molvarec A; Szarka A; Walentin S; Beko G; Karádi I; Prohászka Z; Rigó J
    Reprod Biol Endocrinol; 2011 Sep; 9():124. PubMed ID: 21906313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of the anti-angiogenic thrombospondin 2 are elevated in pre-eclampsia.
    Stenczer B; Molvarec A; Veresh Z; Gullai N; Nagy GR; Walentin S; Szijártó J; Rigó J
    Acta Obstet Gynecol Scand; 2011 Nov; 90(11):1291-5. PubMed ID: 21682699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships of serum placental growth factor and soluble fms-like tyrosine kinase-1 with fetal and uterine artery Doppler indices in pre-eclampsia.
    Li J; Cai A; Yuan Q; Ding H; Zhao D
    Int J Gynaecol Obstet; 2019 May; 145(2):176-181. PubMed ID: 30801711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of angiogenic, anti-angiogenic and vasoactive factors in pre-eclamptic African women: early- versus late-onset pre-eclampsia.
    Govender L; Mackraj I; Gathiram P; Moodley J
    Cardiovasc J Afr; 2012 Apr; 23(3):153-9. PubMed ID: 22555639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia.
    Staff AC; Braekke K; Harsem NK; Lyberg T; Holthe MR
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):33-9. PubMed ID: 15935542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in Antioxidant Micronutrient Concentrations in Placental Tissue, Maternal Blood and Urine and the Fetal Circulation in Pre-eclampsia.
    Kurlak LO; Scaife PJ; Briggs LV; Broughton Pipkin F; Gardner DS; Mistry HD
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lectin pathway proteins of the complement system in normotensive pregnancy and pre-eclampsia.
    Larsen JB; Andersen AS; Hvas CL; Thiel S; Lassen MR; Hvas AM; Hansen AT
    Am J Reprod Immunol; 2019 Apr; 81(4):e13092. PubMed ID: 30672631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating angiogenic factors in pregnancies complicated by pre-eclampsia.
    Varughese B; Bhatla N; Kumar R; Dwivedi SN; Dhingra R
    Natl Med J India; 2010; 23(2):77-81. PubMed ID: 20925202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.
    De Vivo A; Baviera G; Giordano D; Todarello G; Corrado F; D'anna R
    Acta Obstet Gynecol Scand; 2008; 87(8):837-42. PubMed ID: 18607829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic profile in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort.
    Jääskeläinen T; Heinonen S; Hämäläinen E; Pulkki K; Romppanen J; Laivuori H;
    Pregnancy Hypertens; 2018 Oct; 14():252-259. PubMed ID: 29803331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies.
    Dröge L; Herraìz I; Zeisler H; Schlembach D; Stepan H; Küssel L; Henrich W; Galindo A; Verlohren S
    Ultrasound Obstet Gynecol; 2015 Mar; 45(3):286-93. PubMed ID: 25491901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
    Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK; Chandel N; Jain V; Jha V
    J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
    Nzelu D; Biris D; Karampitsakos T; Nicolaides KK; Kametas NA
    Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
    Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
    J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble fms-like tyrosine kinase-1 in HIV infected pre-eclamptic South African Black women.
    Govender N; Moodley J; Gathiram P; Naicker T
    Placenta; 2014 Aug; 35(8):618-24. PubMed ID: 24880209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.